MyCelx Technologies Corporation Director/PDMR Shareholding (9828J)
03 May 2022 - 4:01PM
UK Regulatory
TIDMMYX TIDMMYXR
RNS Number : 9828J
MyCelx Technologies Corporation
03 May 2022
2 May 2022
MYCELX Technologies Corporation
("MYCELX" or the "Company" (AIM: MYX)
Dealing by Director
The Company announces that it was notified on 2 May 2022 by Hal
Alper, President, Chief Science Officer and a Director of the
Company, that on 10 November 2021 he sold 22,500 Common Shares at a
price of GBP0.70 per Common Share. Following this transaction, he
continues to be interested in 1,219,546 Common Shares representing
5.31 per cent of the present issued capital of the Company and in
124,339 options over the Company's Common Shares.
For further information please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO Tel: +1 888 306 6843
Kim Slayton, CFO
Canaccord Genuity, Nominated Adviser
Henry Fitzgerald-O'Connor Tel: + 44 20 7523 8000
Gordon Hamilton
Celicourt
Mark Antelme Tel: +44 20 8434 2754
Jimmy Lea
Notification of transactions of persons discharging managerial
responsibility or connected persons
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Hal Alper
---------------------------- ----------------------------------
2 Reason for the notification
----------------------------------------------------------------
a) Position/status Director
---------------------------- ----------------------------------
b) Initial notification Initial notification
/Amendment
---------------------------- ----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------
a) Name MYCELX Technologies Corporation
---------------------------- ----------------------------------
b) LEI 213800UJZINIK2VD1G48
---------------------------- ----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
----------------------------------------------------------------
a) Description of the
financial instrument, Common shares of US$0.025
type of instrument
Identification code USU624551078
---------------------------- ----------------------------------
b) Nature of the transaction Disposal of Common Shares
---------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
GBP0.70 22,500
----------
---------------------------- ----------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
---------------------------- ----------------------------------
e) Date of the transaction 10/11/2021
---------------------------- ----------------------------------
f) Place of the transaction London Stock Exchange
---------------------------- ----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFFFEIELIFIIF
(END) Dow Jones Newswires
May 03, 2022 02:01 ET (06:01 GMT)
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jul 2023 to Jul 2024